Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.00
21.03.20
-
04.04.20
3.16%
04.04.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€26.47
20.03.20
-
04.11.21
12.19%
21.11.20

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€67.00
20.03.20
-
04.11.21
2.09%
21.11.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.86
20.03.20
€78.00
04.11.21
-24.02%
05.11.21

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€456.60
19.03.20
€500.00
20.03.20
-6.61%
20.03.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€76.81
19.03.20
€85.00
19.03.20
-3.91%
19.03.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€458.40
19.03.20
-
25.03.20
-8.28%
25.03.20

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€131.66
18.03.20
-
25.03.20
-15.22%
25.03.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.60
18.03.20
-
19.03.20
7.69%
19.03.20

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.32
18.03.20
€150.00
12.10.20
6.54%
12.10.20

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€228.95
18.03.20
€255.00
04.11.21
-7.05%
05.11.21

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.80
18.03.20
€37.95
07.05.20
23.39%
07.05.20

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€26.85
18.03.20
€37.95
23.08.20
17.31%
23.08.20

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€66.01
18.03.20
-
18.05.20
6.77%
18.05.20

buy
Viatris Inc.

Start price
Target price
Perf. (%)
€14.80
17.03.20
€16.00
04.11.21
0.00%
06.01.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Small cyclical dependencies
Top 10 in its market
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.04
17.03.20
€33.21
04.11.21
47.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Resmed Inc.

Start price
Target price
Perf. (%)
€120.00
16.03.20
€140.00
04.11.21
87.75%
05.11.21

buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€274.00
14.03.20
-
16.03.20
-5.84%
16.03.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€66.00
14.03.20
-
16.03.20
-8.18%
16.03.20

buy
Quest Diagnostics Inc.

Start price
Target price
Perf. (%)
€89.00
13.03.20
-
16.03.20
-6.74%
16.03.20

buy
Viatris Inc.

Start price
Target price
Perf. (%)
€12.60
13.03.20
-
13.05.20
22.97%
13.05.20

buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€70.50
12.03.20
€145.00
04.11.21
119.55%
05.11.21

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€401.20
12.03.20
-
16.03.20
-1.25%
16.03.20

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€50.58
11.03.20
€55.00
04.11.21
1.07%
05.11.21

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€117.78
11.03.20
€150.00
04.11.21
20.58%
05.11.21

Could be worthwhile Investment >10% per year